INS and type 2 diabetes mellitus: In addition, in vitro experiments of insulin treatment in patients with T2Dhave shown that exogenous insulin raises the level of betatrophin in patients with T2D compared to those of the same gender, age, blood lipid levels, and BMI, further demonstrating that insulin directly up-regulates betatrophin expression.